Outputs1) 2-Day In-Person ConferenceThis project will take the form of a 2-day In-person Conference, which will be held in Chinese Taipei in April 2025. This project will consist of a one-and- a-half-day conference and a half-day site visit.
1) Conference:
a. Purpose: Introducing practical applications of dengue prevention and control in the post-COVID-19 era with the delegates of member economies who participate in this project in preparation for future health crisis. b. Duration: One and a half day. The length of any session will be within 3 hours.
c. Location: Tainan City.
d. Participants: Health policy makers in public and private partnerships, public health and environment officers, professionals and experts in dengue vectors, epidemiologist research, laboratory diagnosis along with clinical management, as well as representatives of private sectors from APEC economies and non-APEC stakeholders. The number of participants is expected to be at least 80-100 from 13-15 APEC economies.
e. The conference will encompass 2-3 sessions/day, and the discussion topics through the speeches will include:
I. Experiences in and cases of public-private partnerships for dengue prevention and control in the post-COVID-19 era will be shared and discussed in relevant speeches.
II. Current development and challenges of dengue vaccines that are assessed for public health impact.
III. Latest research development in vector surveillance and control with cooperation from private sectors or academia.
IV. Demonstration of innovative real-time and integrated information models developed by digital technologies for disease and vector surveillance, environmental management, and risk management.
2) Site visit
a. Purpose: Enhancing the capacity of developing member economies in this region by exchanging the latest research and knowledge during the site visit.
b. Duration: A half day (on the second day afternoon).
c. Location: Mosquito-borne diseases control research center in Tainan.
d. Discussion topics: The center’s specialists will be on site to provide insights into the potential of using biological control strategies against dengue with Wolbachia models, which may block mosquito-borne viruses that can be transmitted to people.
2) Conference Report
The Conference Report will comply with the APEC publication and logo guidelines and APEC copyright-related policies. The expected length of the report will be within 30 pages excluding annexes. The rough structure of the document will include: cover page, table of contents, introduction, and topic- based summaries of presentations, as well as conclusions and recommendations after data analysis.
Outcomes
1) Greater awareness of global warming and its unprecedented impact on flooding, thereby affecting vectors and dengue outbreaks.
2) Improving knowledge of advanced dengue prevention strategies, such as vector surveillance, environmental management, vector control and studies, and digital technology (epidemic geographic information systems, risk prediction models, unmanned ground vehicle systems, etc.).
3) Deeper understanding of how to manage dengue and severe dengue during epidemic outbreaks by sharing case studies, best practices and experiences in disease surveillance, public awareness campaigns, community mobilization, laboratory diagnosis, and clinical case management and treatment.
4) Improving trust to build an effective network and establish long-term collaborative relationship for ongoing exchange of epidemic information, technology applications, improvements, and innovation.
Beneficiaries
All APEC economies are welcome to participate in the project. The target participants of the project are dengue prevention policy makers and officials, public health officials, quarantine officers, experts in communicable disease prevention and competent authorities, the private sector (e.g., pest control operators), academia, NGOs, and IGOs. The 2-day In-person Conference will provide an opportunity for these groups to emphasize a whole-of-government and a whole-of-society approach to securing dengue prevention and control in the post-COVID-19era.